Galantamine (Reminyl) for Alzheimer's Disease
Galantamine hydrobromide (Reminyl), a tertiary alkaloid and phenanthrene derivative extracted from daffodil bulbs, is now being marketed for oral treatment of mild to moderate Alzheimer's disease. Galantamine is the fourth acetylcholinesterase inhibitor approved for this indication....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Galantamine (Reminyl) for Alzheimer's Disease
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1107
Article Code: 1107a
Date: June 25, 2001
Volume: 43
Pages: 53-54
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1107
Article Code: 1107a
Date: June 25, 2001
Volume: 43
Pages: 53-54
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)